Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma
Clinical trial NCT01196416 · COMPLETED
Trial details
- NCT number
- NCT01196416
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2015-08-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.